http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_98c64be0b5688e61c0239911f8833c11
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Babich |
| name | John W Babich John W. Babich |
| given-name | John W. John W |
| organization-name | Department of Chemistry, Syracuse University, Syracuse, New York 13244, and Biostream Inc., 160 Second Street, Cambridge, Massachusetts 02142 Department of Radiology Cornell University Ithaca New York USA Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts. Radiology Weill Cornell Medicine New York NY 10065 USA Department of Chemistry, Syracuse University, Syracuse, New York 13244, Biostream, Inc., 160 Second Street, Cambridge, Massachusetts 02142, Department of Chemistry, University of New Orleans, New Orleans, Louisiana 70148, and Department of Chemistry, McMaster University, Hamilton, ON L8S 4M1, Canada Molecular Insight Pharmaceuticals, Inc., 160 Second Street, Cambridge, Massachusetts 02142, United States Division of Nuclear Medicine of the Department of Radiology, The Trauma Service of the Department of Surgery, Massachusetts General Hospital and Shriners Hospital for Children–Boston and Harvard Medical School, Boston, MA, 02114; and Massachusetts Institute of Technology, Cambridge, MA 02139 4Department of Radiopharmacy, Weill Cornell Medical College, New York, New York 1Molecular Insight Pharmaceuticals, Cambridge, Massachusetts; and Steele Laboratory for Tumor Biology, Department of Radiation Oncology, Center for Imaging and Pharmaceutical Research and Division of Nuclear Medicine, Department of Radiology, Harvard Medical School and Massachusetts General Hospital, Boston, MA 02114 Molecular Insight Pharmaceuticals, Inc., 160 Second Street, Cambridge, Massachusetts 02142, Department of Chemistry, Syracuse University, Syracuse, New York 13244, and Department of Chemistry, McMaster University, Hamilton, Canada ON L8S4MI From the Division of Nuclear Medicine, University of Maryland Hospital and School of Medicine, Baltimore (V.D., M.Y.M.); Cardiovascular Consultants, Kansas City, Mo (T.M.B.); Cardiovascular Division, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY (S.R.B.); Oklahoma Heart Institute, Tulsa (R.D.P.); Molecular Insight Pharmaceuticals, Inc, Cambridge, Mass (A.E.G., J.W.B.); and Division of Cardiology, Tufts-New England Medical Center and Tufts University... Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge, Massachusetts 02142, Division of Nuclear Medicine of the Department of Radiology, Massachusetts General Hospital, and the Department of Radiology, Harvard Medical School, Boston, Massachusetts 02115, Department of Chemistry, McMaster University, Hamilton, Ontario, Canada L8S 4M1, and Department of Chemistry, Syracuse University, Syracuse, New York 13244 Molecular Insight Pharmaceuticals, Inc., 160 Second Street, Cambridge, Massachusetts 02142 Department of Chemistry, Syracuse University, Syracuse, New York 13244, Department of Chemistry, McMaster University, Hamilton, Ontario Canada L8S 4M1, and Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge, Massachusetts 02142 Division of Radiopharmacy, Department of Radiology, Cornell University, New York, NY, USA Department of Radiology, Citigroup Biomedical Imaging Center Department of Chemistry, Syracuse University, Syracuse, New York 13244, and Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge, Massachusetts 02142 Weill Cornell Medical College 445 E 69th St New York NY 10021 Division of Nuclear Medicine, Department of Radiology, Massachusetts General Hospital, and Department of Radiology, Harvard Medical School, Boston,1 and Department of Chemistry, Syracuse University, Syracuse, New York 13244, Department of Chemistry, McMaster University, Hamilton, Ontario, Canada L8S 4M1, and Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario Canada L8S 4M1, and Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge, Massachusetts 02142 Department of Chemistry, McMaster University, Hamilton, Ontario, Canada L8S 4M1, The Medical Physics and Applied Radiation Sciences Unit, McMaster University, Hamilton, Ontario, Canada L8S 4M1, Department of Chemistry, Syracuse University, Syracuse, New York 13244-4100, and Molecular Insight Pharmaceuticals Inc., Cambridge, Massachusetts 02142 Department of Chemistry, McMaster University, Hamilton, ON, Canada L8S 4M1, The Medical Physics and Applied Radiation Sciences Unit, McMaster University, Hamilton, ON, Canada, L8S 4M1, Department of Chemistry, Syracuse University, Syracuse, New York 13244-4100, and Molecular Insight Pharmaceuticals Inc., Cambridge, Massachusetts 02142 Departments of Chemistry and Medical Physics & Applied Radiation Sciences, McMaster University, Hamilton, ON, Canada, L8S 4M1, Department of Chemistry, Syracuse University, Syracuse, New York 13244-4100, Molecular Insight Pharmaceuticals Inc., Cambridge, Massachusetts 02142, and Department of Radiology, University of Pennsylvania, Philadelphia, Pennsylvania 19104 Molecular Insight Pharmaceuticals, Cambridge, Massachusetts; and Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts 02142 Department of Chemistry, Syracuse University, Syracuse, New York 13244, Department of Chemistry, McMaster University, Hamilton, ON L8S 4M1, Canada, and Biostream, Inc., 160 Second Street, Cambridge, Massachusetts 02142 Department of Radiology, Weill Cornell Medicine, New York, New York 10065, United States Russell H. Morgan Department of Radiology and Radiological Sciences, Department of Pharmacology & Molecular Sciences, Department of Urology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21231, Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts 02142 Department of Chemistry, Syracuse University, Syracuse, New York 13244, and Molecular Insight Pharmaceuticals Inc., 260 Second Street, Cambridge, Massachusetts 02142 Department of Chemistry and The Medical Physics and Applied Radiation Sciences Unit, McMaster University, Hamilton, ON, Canada L8S 4M1, Department of Chemistry, Syracuse University, Syracuse, New York 13244-4100, and Molecular Insight Pharmaceuticals Inc., Cambridge, Massachusetts 02142 Division of Nuclear Medicine of the Department of Radiology, Massachusetts General Hospital and the Department of Radiology, Harvard Medical School, Boston, MA 02114; Center for Molecular Targeting, Northeastern University, Boston, MA 02210; Hybridon, Inc., Cambridge, MA 02139; and Imaging Biopharmaceuticals, Cambridge, MA 02142 Molecular Insight Pharmaceuticals, 160 Second Street, Cambridge, Massachusetts 02142, United States Research & Development Department, Molecular Insight Pharmaceuticals, Inc., Cambridge, Massachusetts. Authors' Affiliations: 1Molecular Insight Pharmaceuticals, Cambridge, Massachusetts; 2University of Glasgow, Glasgow, United Kingdom; 3Johns Hopkins Medical Institutions, Baltimore, Maryland; 4Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany; 5Radiation Dosimetry Services, Charlotte, Virginia; and 6Vanderbilt University, Nashville, Tennessee |
Incoming Links
Total number of triples: 150.